Acute Respiratory Distress Syndrome
- Health
Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®
Neuchatel, Switzerland: Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which…
Read More » - Health
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19
Ingelheim, Germany: Trial will evaluate BI 764198, a novel first-in-class compound, for hospitalized people infected with SARS-CoV-2 with severe respiratory…
Read More » - India
DCGI gives Nod for Restricted Emergency Use to Itolizumab for moderate to severe COVID-19 patients
Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been granted Restricted…
Read More »